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Steroid abuse by a minority of top class athletes is well recognised. Abuse by competitive body builders is 
thought to be common but has caused less public concern. Recreational body builders attending gymnasiums 
also abuse steroids1 but the frequency and patterns of use and the associated problems are less well known.  
Among other side effects androgenic steroids induce hypogonadotrophic hypogonadism with subsequent 
azoospermia.2 Over the past year we have noted an increased number of men attending the infertility clinic who 
have been using anabolic steroids for body building. This has been associated with an apparent substantial 
increase in body building as a recreational pastime in the north east.  
We are concerned about the lack of understanding of the consequences of steroid use by users and providers 
and the ease with which the diagnosis can be missed. The following five cases illustrate the problems.  
Case reports  
Case 1--A couple (husband aged 29) requested in vitro fertilisation after primary subfertility for three years. 
Results of two semen analyses arranged by the general practitioner in early 1994 were normal (sperm densities 
80x109 and 150x109/l). At presentation the husband was severely oligospermic (sperm densities nil and 
<100x106/l). His hobby was weightlifting and he admitted to taking oral steroids for two weeks 12 months earlier. 
Examination showed a normal muscular male physique with normal secondary sexual characteristics. However, 
follicle stimulating hormone and testosterone concentrations were very low, confirming steroid use. He admitted 
to taking a "protein health drink" which was made up by the gymnasium before training. Three months after 
stopping this drink his sperm density was 100x109/l.  
Case 2--A couple (husband aged 35) were referred for in vitro fertilisation with donor sperm. The husband owned 
a gymnasium and his hobby was body building. At the age of 24, six months after mumps without testicular 
involvement, a semen sample had shown azoospermia with maturation arrest on testicular biopsy. They were 
referred to a large tertiary referral unit. Knowing he was azoospermic from an apparent other cause, the husband 
had started and continued to take anabolic steroids without informing anyone. Azoospermia was confirmed and 
they received unsuccessful donor insemination. He stopped steroids at the age of 31 because of fear of the 
general side effects at that age. Four years later routine semen assessment before in vitro fertilisation showed 
normal sperm densities (90x109 and 59x109/l). For several years they had almost abstained from intercourse 
because they thought they had no chance of conceiving naturally.  
Case 3--A couple (husband aged 28) attended for investigation of secondary subfertility for 12 months. Each had 
a child from a previous relationship. The husband was azoospermic. He admitted to body building and regular use 
of oral testosterone from 1990 to September 1994. In an attempt to reverse the effects of the steroid "treatment" 
he was given human chorionic gonadotrophin injections by the supervisors of the gymnasium that he attended. 
His wife was unaware of the drug abuse. Five months after stopping steroids his sperm density was 30x109/l.  
Case 4--A couple (husband aged 27) had primary infertility for over two years. The husband had been a body 
builder since the age of 18 because of bullying. He had used steroids from the age of 21 but stopped 10 months 
before the consultation. Semen analysis results were: January 1995, 1.9x109/l (99% motile); June 1995, 11x109/l 
(16% motile); September 1995, 14x109/l (36% motile). He provided a detailed list of the oral and intramuscular 
drugs that he had used (needles being obtained from the needle exchange programme). These were: 1987 
methandienone (Dianabol; six months); 1988 methandienone (Dianabol; four months), nandrolone (Deca-
Durabovan), and intramuscular methyltestosterone (Testoviron; three to four weeks); 1990 oral mesterolone (Pro-
Viron; two years) and oral stanozolol (Stromba); 1992 intramuscular methenolone (Primobolan; six months on, six 
months off) and oral nandrolone (Anabolin); 1993 oral methenolone (Primobolan; one year) and testosterone 
propionate (Testex; three months on, three months off for one year); 1994 intramuscular stanozolol (Stromba) 
and oral methandienone (Dianabol). He stopped the drugs in May 1994.  
Case 5--A couple (husband aged 28) presented with two years of primary infertility. The husband attended a 
gymnasium regularly for recreation and weight training. For five months before presentation he had taken steroids 
given to him by friends at the gymnasium. He doubled the dose that his friends suggested. His sperm count was 
5x109/l with 80% motility. Pregnancy was achieved about six months after stopping steroids.  
Comment  
These cases illustrate several different issues relating to steroid abuse. The great secrecy surrounding abuse 
hides it from doctors and even close relatives. Some body builders might even be taking steroids without their 
knowledge. As a result clinicians should be aware of possible undisclosed abuse. The lack of awareness of the 
implications of steroid abuse is shown by the polypharmacy used, the carelessness of dosage, and the young age 
at which the problem starts.  
There are no detailed epidemiological studies available in the United Kingdom about the recreational use of 
anabolic steroids, most information being anecdotal. However, there is no doubt that usage is common and that 
the prevalence has risen in the past 10-20 years. Perry et al, alerted by an apparent increase in steroid users 
attending a needle exchange programme, estimated that 38.8% of gymnasium attenders used these drugs.1 
Identifying the true prevalence is fraught with problems which relate to the secrecy surrounding use and the illicit 
means by which the drugs are obtained. Our patients estimated that between 100 and 300 men regularly 
attended each gymnasium and that between a quarter and three quarters were taking steroids.  
Adverse effects of anabolic steroids are recognised but have mostly been studied using therapeutic doses. The 
doses used by body builders may be up to 40 times higher than therapeutic doses. Furthermore, the multiple 
preparations used makes studying the adverse effects of individual drugs almost impossible. The adverse effects 
on male fertility described above are well known3 and are being developed for contraceptive use. It should also be 
remembered that other adverse effects include alteration in lipid concentrations, liver disease, jaundice, hepatic 
tumours, gynaecomastia, mood changes, reduced libido, dependence withdrawal effects, and prostatic 
carcinoma.4 5 Use among young teenagers (our patients reported boys of 15 being given steroids) can have 
permanent effects on growth. Awareness of the increasing abuse of these drugs is thus important to all clinicians.  
Data from the development of androgenic steroids for male contraception indicate that reversal of effects can 
take up to 12 months after stopping the drugs.2 Case reports indicate that problems may persist for up to three 
years.6 7 There is no evidence that human chorionic gonadotrophin would have any protective effect, and men 
abusing steroids must be warned of a potential long term adverse effect.  
We questioned our patients about the advice given to them about side effects. Written information was obtained 
from body building magazines and "underground steroid booklets." The gymnasiums gave no or very limited 
information. All patients reported that they were unaware of the severe side effects of steroids and would never 
use them again.  
Our main concern is that young men are taking anabolic steroids for recreational use without knowing the 
potentially serious consequences. Furthermore, doctors must be made aware of the potential abuse of steroids by 
male patients, as this information may not be volunteered. These men are usually easily recognised by their 
physique and often have small testicles. Accurate history taking in these men is difficult but direct questions 
should be asked.  
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